Central Nervous System Tumors Clinical Trial
Official title:
Phase II Trial of Pemetrexed and Temozolomide in Treating Patients With Relapsed PCNSL
In this trial, we will treat relapsed PCNSL with temozolomide, pemetrexed. Our objective was to assess our treatment strategies' availability based on response rates, progression-free survival (PFS), median PFS, and toxicity.
The best reported outcomes of PCNSL treatment are high-dose methotrexate-based chemotherapy combined with whole-brain radiation therapy (WBRT). Despite aggressive therapy, however, nearly 50% of patients will relapse within 24 months of diagnosis. Furthermore, the application of high-dose methotrexate-based regimen is complex, needing be hydrated, alkalified and detoxified, and treatment-related toxicity mortality is severe. In an attempt to improve upon these poor results and reduce treatment-related side effects, we will treat about 15-20 relapsed PCNSL patients who was fail in high-dose methotrexate-based chemotherapy. Our objective is to assess our treatment strategies' availability based on response rates, progression-free survival (PFS), median PFS, and toxicity. ;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00876993 -
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
|
Phase 1 | |
| Completed |
NCT00003935 -
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
|
Phase 1 | |
| Terminated |
NCT00107471 -
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
|
Phase 1/Phase 2 | |
| Completed |
NCT00003573 -
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
|
Phase 2 | |
| Recruiting |
NCT05235074 -
OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
|
Phase 1/Phase 2 | |
| Suspended |
NCT05308407 -
POWER UP: Participating Online While Exercising to Recover Using Play
|
N/A | |
| Terminated |
NCT00477503 -
Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
|
Phase 1 | |
| Withdrawn |
NCT00109798 -
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
|
N/A | |
| Completed |
NCT00003141 -
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
|
Phase 1 | |
| Completed |
NCT00003203 -
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
|
Phase 2 | |
| Completed |
NCT02462629 -
Study of BLZ-100 in Pediatric Subjects With CNS Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT01735747 -
Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
|
Phase 2 | |
| Recruiting |
NCT00607984 -
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
|
N/A | |
| Completed |
NCT00899834 -
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
|
N/A | |
| Completed |
NCT00066248 -
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
|
Phase 2 | |
| Completed |
NCT00187226 -
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
|
Phase 2 | |
| Completed |
NCT02793466 -
Durvalumab in Pediatric and Adolescent Patients
|
Phase 1 | |
| Withdrawn |
NCT01052363 -
OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
|
Phase 1 | |
| Completed |
NCT00047320 -
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
|
Phase 2 | |
| Completed |
NCT00945828 -
Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors
|
N/A |